Structural basis for germline antibody recognition of HIV-1 immunogens
Structural basis for germline antibody recognition of HIV-1 immunogens
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germline bNAb recognition of HIV-1 envelope glycoprotein (Env). The VRC01-class bNAb family derived from the VH1-2*02 germline allele arose in multiple HIV-1–infected donors, yet targets the CD4-binding site on Env with common interactions. Modified forms of the 426c Env that activate germline-reverted B cell receptors are candidate immunogens for eliciting VRC01-class bNAbs. We present structures of germline-reverted VRC01-class bNAbs alone and complexed with 426c-based gp120 immunogens. Germline bNAb–426c gp120 complexes showed preservation of VRC01-class signature residues and gp120 contacts, but detectably different binding modes compared to mature bNAb-gp120 complexes. Unlike typical antibody-antigen interactions, VRC01–class germline antibodies exhibited preformed antigen-binding conformations for recognizing immunogens. Affinity maturation introduced substitutions increasing induced-fit recognition and electropositivity, potentially to accommodate negatively-charged complex-type N-glycans on gp120. These results provide general principles relevant to the unusual evolution of VRC01–class bNAbs and guidelines for structure-based immunogen design.
- University of California, San Francisco United States
- California Institute of Technology United States
- Rockefeller University United States
- Howard Hughes Medical Institute United States
- Fred Hutchinson Cancer Research Center United States
Models, Molecular, Biomedical and clinical sciences, HIV Antigens, Protein Conformation, HIV Antibodies, HIV Envelope Protein gp120, Crystallography, X-Ray, immunology, Models, biophysics, structural biology, Biology (General), Neutralizing, Crystallography, Q, R, Biophysics and Structural Biology, Biological sciences, Infectious Diseases, Medical Microbiology, HIV/AIDS, Medicine, Protein Binding, 570, QH301-705.5, Science, Immunology, 610, virus, Antibodies, Vaccine Related, Humans, human, Vaccine Related (AIDS), crystallography, Biomedical and Clinical Sciences, Prevention, broadly neutralizing antibodies, Molecular, Health sciences, HIV, Antibodies, Neutralizing, Good Health and Well Being, X-Ray, HIV-1, Sexually Transmitted Infections, Immunization, Biochemistry and Cell Biology
Models, Molecular, Biomedical and clinical sciences, HIV Antigens, Protein Conformation, HIV Antibodies, HIV Envelope Protein gp120, Crystallography, X-Ray, immunology, Models, biophysics, structural biology, Biology (General), Neutralizing, Crystallography, Q, R, Biophysics and Structural Biology, Biological sciences, Infectious Diseases, Medical Microbiology, HIV/AIDS, Medicine, Protein Binding, 570, QH301-705.5, Science, Immunology, 610, virus, Antibodies, Vaccine Related, Humans, human, Vaccine Related (AIDS), crystallography, Biomedical and Clinical Sciences, Prevention, broadly neutralizing antibodies, Molecular, Health sciences, HIV, Antibodies, Neutralizing, Good Health and Well Being, X-Ray, HIV-1, Sexually Transmitted Infections, Immunization, Biochemistry and Cell Biology
14 Research products, page 1 of 2
- 2017IsRelatedTo
- 2016IsSupplementTo
- 2015IsRelatedTo
- 2015IsSupplementTo
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
26 bioentities, page 1 of 2
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).64 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
